Merck & Co., Inc.
MRK
$114.29
-$1.58-1.36%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.31% | 1.68% | 1.82% | 4.10% | 6.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.31% | 1.68% | 1.82% | 4.10% | 6.74% |
| Cost of Revenue | 0.80% | -3.78% | -5.02% | -5.08% | -7.65% |
| Gross Profit | 1.47% | 3.35% | 4.00% | 7.19% | 11.93% |
| SG&A Expenses | 0.13% | 0.21% | 2.89% | 3.54% | 2.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.71% | -20.34% | -11.27% | -10.45% | -11.53% |
| Operating Income | -3.82% | 62.51% | 32.91% | 39.18% | 55.24% |
| Income Before Tax | 5.67% | 59.02% | 25.65% | 415.96% | 955.37% |
| Income Tax Expenses | 0.07% | 78.10% | 83.18% | 70.94% | 85.38% |
| Earnings from Continuing Operations | 6.59% | 56.57% | 19.39% | 652.52% | 4,444.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 50.00% | 33.33% | 25.00% | -30.77% | -33.33% |
| Net Income | 6.64% | 56.68% | 19.44% | 656.03% | 4,589.59% |
| EBIT | -3.82% | 62.51% | 32.91% | 39.18% | 55.24% |
| EBITDA | -1.96% | 51.84% | 29.53% | 35.77% | 47.57% |
| EPS Basic | 7.88% | 57.90% | 19.91% | 654.34% | 4,574.05% |
| Normalized Basic EPS | -4.14% | 65.44% | 37.54% | 42.70% | 57.71% |
| EPS Diluted | 8.24% | 58.71% | 20.41% | 669.06% | 4,968.12% |
| Normalized Diluted EPS | -4.03% | 65.89% | 37.89% | 42.79% | 57.78% |
| Average Basic Shares Outstanding | -1.20% | -0.68% | -0.33% | -0.14% | -0.09% |
| Average Diluted Shares Outstanding | -1.34% | -0.82% | -0.44% | -0.09% | -0.03% |
| Dividend Per Share | 5.19% | 5.26% | 5.33% | 5.41% | 5.48% |
| Payout Ratio | -0.02% | -0.33% | -0.12% | -0.86% | -0.98% |